help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 1, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0399
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
22/2/513    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halperin, J.
Right arrow Articles by Gibori, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halperin, J.
Right arrow Articles by Gibori, G.

Submitted on August 20, 2007
Accepted on October 25, 2007

Prolactin Signaling Through the Short Form of Its Receptor Represses FOXO3 and its Target Gene Galt Causing a Severe Ovarian Defect

Julia Halperin, Sangeeta Y. Devi, Shai Elizur, Carlos Stocco, Aurora Shehu, Diane Rebourcet, Terry G. Unterman, Nancy D. Leslie, Jamie Le, Nadine Binart, and Geula Gibori*

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA; Inserm U845, Univ Paris-Descartes, Faculté de Médecine René Descartes, Site Necker, UMR-S845, Paris, F-75015, France; Department of Medicine, University of Illinois at Chicago and Jesse Brown Veterans Affairs Medical Center, Chicago, IL 60612, USA; Division of Human Genetics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH 45229, USA

* To whom correspondence should be addressed. E-mail: ggibori{at}uic.edu.

Prolactin is a hormone with over 300 biological activities. Although the signaling pathway downstream of the long form of its receptor (RL) has been well characterized, little is known about PRL actions upon activation of the short form (RS). Here, we show that mice expressing only RS exhibit an ovarian phenotype of accelerated follicular recruitment followed by massive follicular death leading to premature ovarian failure (POF). Consequently, RS-expressing ovaries of young adults are depleted of functional follicles and formed mostly by interstitium. We also show that activation of RS represses the expression of the transcription factor FOXO3 and that of the enzyme galactose-1-phosphate urydiltransferase (Galt), two proteins known to be essential for normal follicular development. Our finding that FOXO3 regulates the expression of Galt and enhances its transcriptional activity indicates that it is the repression of FOXO3 by PRL acting through RS that prevent Galt expression in the ovary and causes follicular death. Co-expression of RL with RS prevents PRL inhibition of Galt, and the ovarian defect is no longer seen in RS transgenic mice that co-express RL, suggesting that RL prevents RS-induced ovarian impairment. In summary, we show that prolactin signals through RS and causes, in absence of RL, a severe ovarian pathology by repressing the expression of FOXO3 and that of its target gene Galt. We also provide evidence of a link between the POF seen in mice expressing RS, in mice with FOXO3 gene deletion as well as in human with Galt mutation.


Key words: Prolactin • Prolactin Receptor Short • FOXO3 • Galt • premature ovarian failure







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society